FLT3 and acute myeloid leukemia: STAT5 is a downstream effector of FLT3 signaling in FLT3(ITD)-positive AML cells and we observed that AIU2001 dose-dependently inhibited phosphorylated STAT5 in Molm-13 and MV4-11 cells (Supplementary Figure S3).